Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-08-17
1994-02-15
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3170, A61K 3144, A61K 3140
Patent
active
052867315
ABSTRACT:
This invention provides a method of treating immunoinflammatory bowel disease in a mammal in need thereof which comprises administering an antiimmunoinflammatory amount of rapamycin, alone or in combination with cyclosporin A. As such, rapamycin, alone or in combination with cyclosporin A, is useful in treating bowel diseases such as ulcerative colitis, Crohn's disease, ulcerative proctitis, and the like.
REFERENCES:
patent: 3929992 (1975-12-01), Sehgal et al.
patent: 4996193 (1991-02-01), Hewitt et al.
patent: 5023263 (1991-06-01), Von Burg et al.
patent: 5023264 (1991-06-01), Caufield et al.
patent: 5078999 (1992-01-01), Warner et al.
patent: 5080899 (1992-01-01), Sturm et al.
Mark S. Fradin, et al., J. Am. Acad. Dermatol. 23: 1265 (1990).
C. P. Eng, et al., Transplant. Proc. 23: 868 (1991).
J. E. Kay, Immunology 72: 544 (1991).
C. N. Ellis, J. Am. Med. Assoc. 256: 3110 (1986).
C. N. Ellis, N. E. Jour Med. 324: 277 (1991).
R. R. Martel, Can. J. Physiol. Pharmacol. 55, 48 (1977).
M. J. Staruch, FASEB 3, 3411 (1989).
R. Morris, Med. Sci. Res. 17:877 (1989).
J. G. Meingassner, J. Invest. Dermatol. 98: 851 (1992).
Caufield Craig E.
Musser John H.
Sehgal Surendra N.
American Home Products Corporation
Milowsky Arnold S.
Nutter Nathan M.
LandOfFree
Method of treating immunoinflammatory bowel disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating immunoinflammatory bowel disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating immunoinflammatory bowel disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1207188